Namsos Hospital
34
22
23
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 34 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (34)
Coronary CT Angiography in Non ST-elevation Myocardial Infarction
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Methylphenidate
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Atomoxetine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Dexamphetamine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Lisdexamphetamine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Venlafaxine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Quetiapine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Chlorprothixene
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Lercanidipine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Valsartan
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Paracetamol
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Fluoxetine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Amlodipine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Losartan
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Enalapril
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Ibuprofen
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Irbesartan
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Lamotrigine
Role: collaborator
Bariatric Surgery and Pharmacokinetics of Candesartan
Role: collaborator